financetom
Business
financetom
/
Business
/
Vitamin Shoppe's telehealth service to provide access to weight-loss drugs
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Vitamin Shoppe's telehealth service to provide access to weight-loss drugs
May 8, 2024 6:41 AM

May 8 (Reuters) - Health and wellness products retailer

Vitamin Shoppe said on Wednesday that subscribers to its

telehealth service would have access to weight-loss medications

such as Ozempic, Mounjaro and Rybelsus.

Monthly medication subscription to the retailer's virtual

healthcare platform, Whole Health Rx, starts at an introductory

price of $219, and does not require insurance, the company said

in a statement.

WHY IT'S IMPORTANT

The subscription covers the cost of drugs, whose immense

popularity and high prices are likely to keep them out of reach

for many patients in the coming year.

Developed initially to treat diabetes, GLP-1 drugs have been

shown to help patients lose 15% to 20% of their body weight in

clinical trials by suppressing food cravings.

CONTEXT

Vitamin Shoppe said it was launching Whole Health Rx with weight

management in focus, but would expand the program to cater to

other needs such as testosterone support, hormone replacement

therapy, hair loss and smoking cessation, among others.

Last month, retailer Costco Wholesale ( COST ) offered its roughly

130 million members access to weight-loss programs through its

partnership with online healthcare services provider Sesame,

although its subscription did not cover the cost of weight-loss

drugs.

BY THE NUMBERS

UBS analysts are expecting the global market for GLP-1 class of

drugs to grow to $126 billion by 2029 and identified the

expansion of the obesity market to be a "key driver."

(Reporting by Juveria Tabassum; Editing by Anil D'Silva)

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Circle K Owner Couche-Tard Pursues Talks With 7-11 Operator Seven & I After $38.5B Bid Rejected
Circle K Owner Couche-Tard Pursues Talks With 7-11 Operator Seven & I After $38.5B Bid Rejected
Sep 8, 2024
Alimentation Couche-Tard Inc ( ANCTF )  has approached Seven & i Holdings ( SVNDF )  for discussions after its $38.5 billion offer was declined. The Canadian firm remains interested in the acquisition. What Happened: Seven & i ( SVNDF ) stated that the offer was not in the best interest of its shareholders and could face antitrust issues in the...
China Renaissance shares plunge after 17-month suspension, former chairman's detention
China Renaissance shares plunge after 17-month suspension, former chairman's detention
Sep 8, 2024
HONG KONG (Reuters) - Shares of boutique investment bank China Renaissance ( CSCHF ) fell as much as 72% to a record low on Monday when they resumed trading 17 months after being suspended during a probe involving its then-chairman and CEO Bao Fan. Trading was suspended on April 3, 2023, due to a delay in publishing its 2022 results...
Methanex to acquire OCI's methanol business in $2.05 bln deal
Methanex to acquire OCI's methanol business in $2.05 bln deal
Sep 8, 2024
Sept 8 (Reuters) - Canadian methanol producer Methanex ( MEOH ) said on Sunday it will acquire Dutch green fuel-maker OCI Global's methanol business in a $2.05 billion deal. The deal includes $1.15 billion in cash, the issuance of 9.9 million shares of Methanex ( MEOH ) valued at $450 million, it said, adding that it is taking on about...
Australia's Domino's served with class action on 'misleading' Japan market comments
Australia's Domino's served with class action on 'misleading' Japan market comments
Sep 8, 2024
(Reuters) -Australian pizza chain Domino's Pizza Enterprises said on Monday that it has been served a shareholder class action, which includes an allegation that it engaged in misleading or deceptive conduct around its expected performance in Japan. The company's shares fell 2.5% to A$29.18 to hit their lowest since late August. The proceeding has been filed by Australian legal consultancy...
Copyright 2023-2026 - www.financetom.com All Rights Reserved